Icosagen

Icosagen is a unique European CRDMO, being successfully in the business for more than 25 years as an independent family-owned company. As such, we combine pre-clinical CRO and clinical CDMO development expertise at one single site for therapeutic antibodies, multispecifics, ADCs, and other complex recombinant protein drug candidates. As a CRDMO we discover, develop, and manufacture proteins seamlessly from research concepts into pre-clinical and clinical development stages. This includes everything from small-scale transient productions to stable high producing cell lines, to manufacture clinical GMP materials in our modern GMP facility. In 2024, we continued our partnership with over 100 biotech & pharma companies on 500 projects, producing more than different proteins.